Chongqing Zhifei Biological Products Co., Ltd.
300122
Rank in Stocks
#3767
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Share Price
$1.85
Market Cap
$4.42B
Change (1 day)
2.00%
Change (1 year)
-35.01%
Country
CN
Trade Chongqing Zhifei Biological Products Co., Ltd. (300122)
Category
Healthcare
P/B ratio for Chongqing Zhifei Biological Products Co., Ltd. (300122)
P/B ratio as of October 2026 TTM: 2.01
According to Chongqing Zhifei Biological Products Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.01. At the end of 2023 the company had a P/B ratio of 4.55.
P/B ratio history for Chongqing Zhifei Biological Products Co., Ltd. from 2007 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.01 | -1.48% |
| 2024 | 2.04 | -55.11% |
| 2023 | 4.55 | -21.50% |
| 2022 | 5.80 | -22.97% |
| 2021 | 7.53 | -60.65% |
| 2020 | 19.13 | 107.52% |
| 2019 | 9.22 | 0.14% |
| 2018 | 9.20 | -11.67% |
| 2017 | 10.42 | 54.01% |
| 2016 | 6.77 | -13.59% |
| 2015 | 7.83 | 79.37% |
| 2014 | 4.37 | -19.08% |
| 2013 | 5.39 | 44.13% |
| 2012 | 3.74 | 18.34% |
| 2011 | 3.16 | -18.10% |
| 2010 | 3.86 | -87.83% |
| 2009 | 31.73 | -40.34% |
| 2008 | 53.18 | -30.24% |
| 2007 | 76.24 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.251 | 211.03% |
US
|
|
| 13.2547 | 559.50% |
US
|
|
| 4.208 | 109.37% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 207.61% |
NL
|
